Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
31.47
+1.33 (4.41%)
At close: Jun 26, 2026, 4:00 PM EDT
30.85
-0.62 (-1.97%)
After-hours: Jun 26, 2026, 7:44 PM EDT
Tango Therapeutics Employees
Tango Therapeutics had 137 employees as of December 31, 2025. The number of employees decreased by 18 or -11.61% compared to the previous year.
Employees
137
Change (1Y)
-18
Growth (1Y)
-11.61%
Revenue / Employee
$416,000
Profits / Employee
-$782,715
Market Cap
4.55B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ACADIA Pharmaceuticals | 798 |
| Denali Therapeutics | 507 |
| Relay Therapeutics | 193 |
| Celcuity | 155 |
| Edgewise Therapeutics | 154 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
| Dianthus Therapeutics | 92 |
TNGX News
- 1 day ago - Tango Therapeutics upgraded to Buy from Hold at Jefferies - TheFly
- 4 days ago - Tango Therapeutics Appoints Robert Azelby to Board of Directors - GlobeNewsWire
- 16 days ago - Tango Therapeutics 18.2M share Secondary priced at $30.00 - TheFly
- 17 days ago - Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering - GlobeNewsWire
- 17 days ago - Tango Therapeutics price target raised to $66 from $27 at H.C. Wainwright - TheFly
- 17 days ago - Tango Therapeutics price target raised to $42 from $30 at Canaccord - TheFly
- 18 days ago - Tango Therapeutics announces $500M common stock offering - TheFly
- 18 days ago - Tango Therapeutics Announces Proposed $500 Million Public Offering - GlobeNewsWire